SEM expects revenues to be between $5.4 billion and $5.6 billion, the mid-point of which implies 5.8% growth from the 2024 figure of $5.2 billion.
Select Medical Holdings Corporation (NYSE:SEM ) Q4 2024 Earnings Conference Call February 21, 2025 9:00 AM ET Company Participants Robert Ortenzio - Executive Chairman and Co-Founder Martin Jackson - Senior Executive Vice President of Strategic Finance and Operations Michael Malatesta - Executive Vice President and CFO Conference Call Participants Justin Bowers - Deutsche Bank Ben Hendricks - RBC Capital Markets Joanna Gajuk - Bank of America Operator Good morning, and thank you for joining us today for Select Medical Holdings Corporation's Earnings Conference Call to discuss the Fourth Quarter and Full Year 2024 Results and the Company's Business Outlook. Speaking today are the Company's Executive Chairman and Co-Founder, Robert Ortenzio; the Company's Senior Executive Vice President of Strategic Finance and Operations, Martin Jackson; and Executive Vice President and CFO, Michael Malatesta.
MECHANICSBURG, Pa. , Feb. 20, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE: SEM) today announced results for its fourth quarter and year ended December 31, 2024, its 2025 business outlook, and the declaration of a cash dividend.
MECHANICSBURG, Pa. , Jan. 23, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM), will release the financial results for its fourth quarter and year ended December 31, 2024 on Thursday, February 20, 2025 after the market closes.
Rising expenses and high leverage are impacting Select Medical's prospects.
MECHANICSBURG, Pa. , Dec. 3, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Holdings") (NYSE: SEM), today announced that Select Medical Corporation, a wholly-owned subsidiary of Holdings ("Select"), has completed a private offering (the "Offering") of $550.0 million in aggregate principal amount of its 6.250% senior notes due 2032 (the "notes").
Select Medical (SEM) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
The heavy selling pressure might have exhausted for Select Medical (SEM) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
By separating from Concentra, which specializes in occupational health services, SEM can better allocate resources to its primary segments.
MECHANICSBURG, Pa. , Nov. 25, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE: SEM) today announced that we have completed our previously announced distribution (the "Distribution") of 104,093,503 shares of common stock of Concentra Group Holdings Parent, Inc. ("Concentra") (NYSE: CON) owned by Select Medical Corporation ("SMC"), a wholly owned subsidiary of Select Medical, representing approximately 81.7% of the outstanding shares of Concentra's common stock.